These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 20418720
1. Testosterone and type 2 diabetes. Grossmann M, Gianatti EJ, Zajac JD. Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):247-56. PubMed ID: 20418720 [Abstract] [Full Text] [Related]
2. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Onat A, Hergenç G, Karabulut A, Albayrak S, Can G, Kaya Z. Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445 [Abstract] [Full Text] [Related]
3. Androgens, insulin resistance and vascular disease in men. Kapoor D, Malkin CJ, Channer KS, Jones TH. Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808 [Abstract] [Full Text] [Related]
4. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A. Diabetes Obes Metab; 2004 May; 6(3):208-15. PubMed ID: 15056129 [Abstract] [Full Text] [Related]
5. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes. Kapoor D, Clarke S, Channer KS, Jones TH. Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199 [Abstract] [Full Text] [Related]
6. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552 [Abstract] [Full Text] [Related]
7. Androgens and obesity. Allan CA, McLachlan RI. Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):224-32. PubMed ID: 20418719 [Abstract] [Full Text] [Related]
8. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. Traish AM, Saad F, Guay A. J Androl; 2009 Jun; 30(1):23-32. PubMed ID: 18772488 [Abstract] [Full Text] [Related]
14. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition. Bojesen A, Høst C, Gravholt CH. Mol Hum Reprod; 2010 Jun; 16(6):396-401. PubMed ID: 20231162 [Abstract] [Full Text] [Related]
18. Effective treatments for insulin resistance: trim the fat and douse the fire. Evans JL, Youngren JF, Goldfine ID. Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889 [Abstract] [Full Text] [Related]
19. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560 [Abstract] [Full Text] [Related]